These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38624045)

  • 1. RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response.
    Wu Y; He H; Zheng K; Qin Z; Cai N; Zuo S; Zhu X
    Pigment Cell Melanoma Res; 2024 Jul; 37(4):496-509. PubMed ID: 38624045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
    Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
    Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning.
    Xiao L; He R; Hu K; Song G; Han S; Lin J; Chen Y; Zhang D; Wang W; Peng Y; Zhang J; Yu P
    Apoptosis; 2024 Aug; 29(7-8):1070-1089. PubMed ID: 38615305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of m6A-Related Genes Landscape in Skin Cutaneous Melanoma to Aid Immunotherapy and Assess Prognosis.
    Meng J; Huang X; Qiu Y; Yu M; Lu J; Yao J
    Int J Gen Med; 2021; 14():5345-5361. PubMed ID: 34522131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A- and m5C- modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A- modified LINC00893 regulates cutaneous melanoma cell metastasis.
    Shi HZ; Tian CC; Wu MY; Ma L; Sun JF; Chen H
    Skin Res Technol; 2024 Jul; 30(7):e13842. PubMed ID: 38965799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
    Wu Z; Zhang R; Bao J; Yin M; Wang X
    Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.
    Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z
    Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic m6A modification patterns and score system in melanoma patients.
    Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients.
    Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F
    Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and immune infiltration implications of SIGLEC9 in SKCM.
    Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R
    Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.